Alkermes Stock Trading Halted Today

Published September 22, 2010

Alkermes Stock Trading Halted Today
WALTHAM, Mass.—-Alkermes, Inc. today announced that NASDAQ has halted trading of the company’s common stock this morning. The Psychopharmacologic Drugs Advisory Committee appointed by the U.S.
Read more on Business Wire via Yahoo! Finance

Alkermes Stock Trading Halted Today
WALTHAM, Mass.–(BUSINESS WIRE)–Alkermes, Inc. (NASDAQ: ALKS) today announced that NASDAQ has halted trading of the company’s common stock this morning. The Psychopharmacologic Drugs Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) meets today to review the company’s supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable …
Read more on Business Wire

Alkermes Stock Trading Halted Today
– FDA Advisory Committee Reviewing VIVITROL for Opioid Dependence -WALTHAM, Mass. — Alkermes, Inc. …
Read more on citybizlist Boston